Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Georges M, Gharabawi"'
Autor:
Jasmanda H. Wu, Ibrahim Turkoz, Georges M. Gharabawi, Mary J. Kujawa, Ramy Mahmoud, Dennis A. Revicki, Leah Kleinman, Gahan J. Pandina
Publikováno v:
Journal of Affective Disorders. 118:139-146
Background The Patient-Rated Troubling Symptoms of Depression (PaRTS-D) instrument assesses the presence and troublesomeness of 8 commonly reported depression-related symptoms from the patient's perspective. A post hoc analysis of a double-blind, ran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77d64d4fedea731aaf71828c27cb0379
https://doi.org/10.1016/j.jad.2009.02.019
https://doi.org/10.1016/j.jad.2009.02.019
Autor:
Margaret A. Kirshner, Robert R. Bies, Denise Sorisio, Marci L. Chew, Mark E. Lehman, Georges M. Gharabawi, Benoit H. Mulsant, Ramy A. Mahmoud, Andrew Greenspan, Bruce G. Pollock
Publikováno v:
Journal of the American Geriatrics Society. 56:1333-1341
The objective of this study was to measure the anticholinergic activity (AA) of medications commonly used by older adults. A radioreceptor assay was used to investigate the AA of 107 medications. Six clinically relevant concentrations were assessed f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::111ce965b9c2eb7765b20ea40b540b3a
https://doi.org/10.1111/j.1532-5415.2008.01737.x
https://doi.org/10.1111/j.1532-5415.2008.01737.x
Autor:
Andrew Greenspan, George S. Alexopoulos, Charles F. Reynolds, Cynthia A. Bossie, Ibrahim Turkoz, Carla M. Canuso, Georges M. Gharabawi
Publikováno v:
The American Journal of Geriatric Psychiatry. 16:21-30
The effect of risperidone augmentation of citalopram for relapse prevention in older patients with antidepressant-resistant depression was evaluated.Patients with major depression agedor =55 years who had failed at least one adequate trial of an anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::455ad0df6b5c9b542417f7baf9f315a4
https://doi.org/10.1097/jgp.0b013e31813546f2
https://doi.org/10.1097/jgp.0b013e31813546f2
Autor:
George M. Simpson, Ramy A. Mahmoud, Ibrahim Turkoz, Cynthia A. Bossie, Mary J. Kujawa, Georges M. Gharabawi
Publikováno v:
Journal of Nervous & Mental Disease. 195:976-982
This post hoc analysis explored the role of insight as a mediator of functioning in a 52-week, double-blind, international trial of 323 patients with schizophrenia or schizoaffective disorder receiving risperidone long-acting injectable. Measures inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f0790461bdb3d4593394008974a83e3
https://doi.org/10.1097/nmd.0b013e31815c1982
https://doi.org/10.1097/nmd.0b013e31815c1982
Autor:
Philip D. Harvey, Robert M. Bilder, Richard S.E. Keefe, Georges M. Gharabawi, Michael G. Aman, Gahan Pandina
Publikováno v:
Biological Psychiatry. 62:226-234
Effects of risperidone on cognitive function in children with disruptive behavior disorders (DBDs) and subaverage intelligence quotient (IQ) were assessed.Data from two 6-week, double-blind, placebo-controlled studies (n = 228) were combined, as were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3140714e899649875cef16bcb646f639
https://doi.org/10.1016/j.biopsych.2006.09.036
https://doi.org/10.1016/j.biopsych.2006.09.036
Autor:
Bruce G. Pollock, Georges M. Gharabawi, Margaret A. Kirshner, Mark E. Lehman, Benoit H. Mulsant, Shitij Kapur, Marci L. Chew, Andrew Greenspan, Robert R. Bies
Publikováno v:
Schizophrenia Research. 88:63-72
Background Atypical antipsychotics clozapine, olanzapine, and quetiapine have significant affinity for the muscarinic receptors in vitro, while aripiprazole, risperidone, and ziprasidone do not. Dissimilarity in binding profiles may contribute to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a46fa7a07a37dbd982f3a5b7ec2f71a
https://doi.org/10.1016/j.schres.2006.07.011
https://doi.org/10.1016/j.schres.2006.07.011
Autor:
Cynthia A. Bossie, Steven G. Potkin, Marcia F.T. Rupnow, Michael H. Davidson, J K Trivedi, Colette Kosik-Gonzalez, Young Zhu, Ramy A. Mahmoud, Georges M. Gharabawi, Andrew Greenspan, Victoria Burtea
Publikováno v:
Schizophrenia Research. 85:254-265
This study compared the effects of atypical antipsychotics (risperidone or quetiapine) with placebo and with each other in recently exacerbated patients with schizophrenia requiring hospitalization.This international, randomized, double-blind study i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dee5f5e6306f6206bdb1b9c6f6220ee9
https://doi.org/10.1016/j.schres.2006.03.027
https://doi.org/10.1016/j.schres.2006.03.027
Autor:
Georges M. Gharabawi, Ramy A. Mahmoud, Cynthia A. Bossie, Fiona Dunbar, Carla M. Canuso, Philippe Bouhours, Amy Loescher, Ibrahim Turkoz, Robert A. Lasser, Mark Hyman Rapaport, Charles B. Nemeroff, Martin B. Keller
Publikováno v:
Neuropsychopharmacology. 31:2505-2513
Approximately one-third of persons with depression do not respond to antidepressant monotherapy. Studies suggest that atypical antipsychotic augmentation may benefit these patients. We investigated the longer-term efficacy of risperidone augmentation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5281f3d9d5b88b63769e3b665098fc55
https://doi.org/10.1038/sj.npp.1301113
https://doi.org/10.1038/sj.npp.1301113
Publikováno v:
Schizophrenia Research. 77:129-139
Treatment-emergent tardive dyskinesia (TD) can be a serious side effect of antipsychotic treatment. Atypical antipsychotics are associated with a lower risk for TD than are conventional agents. A long-acting atypical antipsychotic, with more stable b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::065335ad412017ad66b2fc36e543acc5
https://doi.org/10.1016/j.schres.2005.03.015
https://doi.org/10.1016/j.schres.2005.03.015
Publikováno v:
The International Journal of Neuropsychopharmacology. 8:427-438
Modern atypical antipsychotics have advantages over older neuroleptics. We hypothesize that their utility may be further enhanced by sustained drug delivery without daily oral self-dosing. This report examines the effects of a year of treatment with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d356ffaeff0ca9a93bbe8148961b17b
https://doi.org/10.1017/s1461145705005225
https://doi.org/10.1017/s1461145705005225